The Future of Health Care in Rwanda Starts with a Strong Government Partnership

By Samson Radeny, Chief of party, Ingobyi Project, Rwanda ; Katherine Seaton, Editorial Officer Photo by Charles Harris for IntraHealth International.February 13, 2020Just a decade ago, Rwanda struggled to provide high-quality health services. But when the Millennium and Sustainable Development Goals pushed for change, Rwanda was focused, proactive, and determined to provide better for its 12 million people. Now, the country is an example of how hopes for better health care can become a reality.In the past two decades, the maternal mortality rate in Rwanda hasdropped from 1,071 to 210 deaths per 100,000 live births and the under-five mortality rate has dropped from 196 to 50 deaths per 1,000 live births. Now, 90% of women have skilled assistance during delivery, child immunizations have steadily improved and 93% of children aged 12 to 23 months have received all basic vaccines.And that’s just the beginning. Rwanda is making changes in its maternal and child health care, health workforce, infrastructure, and service delivery to achieve universal access to equal and affordable quality health services. It’s also turning its focus to global health security—the country shares a border with the Democratic Republic of Congo, which is currently experiencing the world’s second-largest Ebola epidemic.We sat down with Samson Radeny, the leader of IntraHealth’s Rwanda programs, to discuss what the future of health care looks like in the count...
Source: IntraHealth International - Category: International Medicine & Public Health Authors: Tags: Infectious Diseases Maternal, Newborn, & Child Health Digital Health Leadership and Governance IntraHealth ' s 40th Anniversary Community Health Workers Source Type: news

Related Links:

This article was originally published by the Frontline Health Workers coalition on September 30, 2020.Read it here.
Source: IntraHealth International - Category: International Medicine & Public Health Authors: Tags: COVID-19 Global health security Source Type: news
Condition:   Healthy Interventions:   Biological: Ad26.ZEBOV;   Biological: MVA-BN-Filo Sponsors:   Janssen Vaccines & Prevention B.V.;   Center for Family Health Research (CFHR);   Coalition for Epidemic Preparedness Innovations (CEPI);   Emory University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
The cleverest of enemies thrive on surprise attacks. Viruses—and coronaviruses in particular—know this well. Remaining hidden in animal hosts for decades, they mutate steadily, sometimes serendipitously morphing into more effective and efficient infectious agents. When a strain with just the right combination of genetic codes that spell trouble for people makes the leap from animal to human, the ambush begins. Such was the case with SARS-CoV-2, the coronavirus behind COVID-19, and the attack was mostly silent and insidious at first. Many people infected with SARS-CoV-2 remained oblivious as they served as the v...
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 Magazine Source Type: news
NEW YORK, September 8, 2020 — The CEOs of AstraZeneca (LSE/STO/NYSE: AZN), BioNTech (NASDAQ: BNTX), GlaxoSmithKline plc (LSE/NYSE: GSK), Johnson &Johnson (NYSE: JNJ), Merck (NYSE: MRK), known as MSD outside the United States and Canada, Moderna, Inc. (Nasdaq: MRNA), Novavax, Inc. (Nasdaq: NVAX), Pfizer Inc. (NYSE: PFE), and Sanofi (NASDAQ: SNY), today announced a historic pledge, outlining a united commitment to uphold the integrity of the scientific process as they work towards potential global regulatory filings and approvals of the first COVID-19 vaccines. All nine CEOs signed the following pledge: We, the und...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Our Company Source Type: news
In the last decades, a number of infectious viruses have emerged from wildlife or re-emerged, generating serious threats to the global health and to the economy worldwide. Ebola and Marburg hemorrhagic fevers, Lassa fever, Dengue fever, Yellow fever, West Nile fever, Zika, and Chikungunya vector-borne diseases, Swine flu, Severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and the recent Coronavirus disease 2019 (COVID-19) are examples of zoonoses that have spread throughout the globe with such a significant impact on public health that the scientific community has been called for a rapid int...
Source: Frontiers in Immunology - Category: Allergy & Immunology Source Type: research
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 overnight Source Type: news
Over the past few years, Professor Zhang Yongzhen has made it his business to sequence thousands of previously unknown viruses. But he knew straight away that this one was particularly nasty. It was about 1:30 p.m. on Jan. 3 that a metal box arrived at the drab, beige buildings that house the Shanghai Public Health Clinical Center. Inside was a test tube packed in dry ice that contained swabs from a patient suffering from a peculiar pneumonia sweeping China’s central city of Wuhan. But little did Zhang know that that box would also unleash a vicious squall of blame and geopolitical acrimony worthy of Pandora herself....
Source: TIME: Health - Category: Consumer Health News Authors: Tags: Uncategorized COVID-19 overnight Source Type: news
In this study, we compared the long-term functionality of anti-EBOV glycoprotein (GP) antibodies from EVD survivors with that from volunteers who received the recombinant vesicular stomatitis virus vectored vaccine (rVSV-ZEBOV) during the Phase I clinical trial in Hamburg. Our study highlights important differences between EBOV vaccination and natural infection and provides a framework for comparison with other vaccine candidates.
Source: Viruses - Category: Virology Authors: Tags: Article Source Type: research
Abstract Interspecies transmissions of viruses between animals and humans may result in unpredictable pathogenic potential and new transmissible diseases. This mechanism has recently been exemplified by the discovery of new pathogenic viruses, such as the novel severe acute respiratory syndrome corona virus-2 (SARS-CoV-2) pandemic, Middle-East respiratory syndrome-coronavirus epidemic in Saudi Arabia, and the deadly outbreak of Ebola in West Africa. The. SARS-CoV-2 causes coronavirus disease-19 (COVID-19), which is having a massive global impact in terms of economic disruption, and, above all, human health. The di...
Source: Applied Microbiology and Biotechnology - Category: Microbiology Authors: Tags: Appl Microbiol Biotechnol Source Type: research
More News: Babies | Child Development | Children | Congo Health | e-learning | Ebola | Ebola Vaccine | Epidemics | Epidemiology | Government | Health Insurance | Health Management | Infectious Diseases | Insurance | International Medicine & Public Health | Men | Partnerships | Perinatology & Neonatology | Rwanda Health | Training | Universities & Medical Training | Vaccines | Women